Pillstats
Rx only · Tablet, Film Coated · Oral

Moexipril Hydrochloride

Moexipril Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)30131
US makers3 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.283$0.567$0.850$1.13Dec 2025Apr 2026Jul 2026
$0.946
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
3
Active US suppliers
80%
Top-2 supplier share*

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Glenmark Pharmaceuticals Inc., USAunknown6SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.